Bridging the U.S. - E.U. Gap - The New Commercialization Trend in the Medical Device Sector
From clinical work to commercialization, the non-U.S. market opportunity may lend itself to obtaining further rounds of financing or going public successfully. - October 04, 2012
Investors and CEOs of Biomedical Start-Up Companies Voice Concerns, and Opportunities for Early Commercial Milestones
Are the biggest opportunities for the U.S. biomedical industry's growth and commercialization available outside of the U.S.? According to CEOs, surveyed at the largest gathering of healthcare financiers and executives, commercialization opportunities outside of the U.S. (OUS) are very attractive. - February 08, 2012
MEDICA - Establishing and Building Clinical Evidence in the Early Stages of a Medical Technology
acroMIS does 10% Consulting and 90% Actual Commercial Implementation in Asia, Europe and America Using a Cost-Efficient Process. - November 21, 2011
MedTech Consulting Company acroMIS Launches New Website for Clients Considering Opportunities Outside the U.S.
Online resources at implementation.acroMIS.com on how to implement and develop medical device technology in new markets available just in time for the Digestive Disease Week® (DDW) meeting in Chicago. - May 08, 2011
U.S. Device Start-Up Companies Move Rapidly, Efficiently and Safely Into Early First-In-Man Uses
acroMIS opens markets big enough to drive sustainable profitability outside the U.S. - March 25, 2011
How U.S. Medical Device Startups Benefit from Early Clinical Uses in Europe
Changing Economic and Regulatory Policies Creates Excitement for Launching New Devices Outside of the U.S. - January 13, 2011